Boardminder

    Christopher S. Boerner

    2 boards
    Materials
    As of 8/31/2026

    0.25

    Boardminder Score™

    Bottom 10% of 4,262 directors

    Lower scoreHigher score

    1.6

    Avg Tenure (yrs)

    Shorter tenure than 95% of directors

    ShorterLonger

    —

    Total Compensation

    Board Seats Breakdown
    Bristol-Myers Squibb Company
    BMY
    F500 #96
    Board Chair & Chief Executive Officer
    Healthcare
    Seat Score
    0.26
    Tenure
    2.8 yrs
    Compensation
    —
    Excess Return
    -103.7%
    Colgate-Palmolive Company
    CL
    F500 #214
    Independent Director
    Materials
    Seat Score
    0.25
    Tenure
    0.5 yrs
    Compensation
    —
    Excess Return
    -18.8%